Clinical Trial Update: A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants [Phase 1]

View source ↗

Summary

Phase 1 study to assess whether JNJ-39758979 affects plasma levels of methotrexate in adults with rheumatoid arthritis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JNJ-39758979
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED